Physician profile
Wendi Rice
NPI 1558728782
$19,694.53
in general payments reported to CMS, 2019-2025
15 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 99% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,521 · 2022: $4,875 · 2023: $3,414 · 2024: $1,424 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,225 · Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,225.00 |
| Food and Beverage | $1,074.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14,107.41 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $4,381.45 | 2021 | |
| Astellas Pharma US INC | $522.01 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $170.26 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.26 | 2021-2022 | |
| Biogen, INC. | $73.21 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $70.76 | 2024-2025 | Gemtesa, Myfembree |
| Coopersurgical, INC. | $65.45 | 2024 | Summit Doppler |
| Abbvie INC. | $57.76 | 2021-2023 | |
| Therapeuticsmd, INC. | $48.44 | 2021 | |
| Evofem Biosciences, INC. | $43.86 | 2021-2022 | |
| Shield Therapeutics INC | $22.47 | 2024 | |
| Hologic Sales and Service, LLC | $15.94 | 2021 | |
| Currax Pharmaceuticals LLC | $13.50 | 2025 | Contrave |
| Exeltis, USA INC. | $12.75 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendi Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.